Skip to main content
CDC Website

English

TB Free in the University and College Setting

This 75-minute webinar discusses TB and LTBI testing and treatment for international students in the university and college setting. The webinar includes information on updates to the American College Health Association (ACHA) TB guidelines, LTBI treatment options, and a model for LTBI screening and treatment in the University setting.

TB Elimination: Tuberculin Skin Testing

This information sheet discusses TB testing using the Mantoux tuberculin skin test (TST) to determine whether an individual is infected with Mycobacterium TB. It discusses how the TST is administered, how it is read, how TST reactions are interpreted the classification of the TST skin test reaction, what are false-positive and false-negative reactions, who can receive a TST and how often the test can be repeated, what is a boosted reaction, why two-step testing is conducted, and whether TSTs can be given to persons receiving vaccinations.

TB Elimination: Targeted Tuberculosis Testing and Interpreting Tuberculin Skin Test Results

The information sheet discusses targeted TB testing, the decision to focus on groups at highest risk for latent TB infection (LTBI) and advises appropriate treatment and treatment completion to prevent LTBI progressing to active disease. It explains tuberculin skin testing (TST) and the test reactions that indicate whether an individual has LTBI; lists the criteria for classifying positive TST reactions; and describes persons at risk for developing TB disease including clinical conditions that increase the risk of LTBI becoming TB disease.

Drug-Resistance Tuberculosis

The animation educates viewers on topics related to drug-resistant TB and multidrug-resistant TB, such as treatment plans, basic information on multidrug-resistant TB, and the importance of medication adherence.

Fighting A Deadly Fungus: A New Strategy to Reduce Deaths Due to Cryptococcus

This information sheet points out that the fungus Cryptococcus is the most common cause of meningitis in sub-Saharan Africa, and is a leading cause of death among people with HIV. Although it is not possible to prevent the initial infection with Cryptococcus, screening for cryptococcal antigen can detect disease before meningitis develops so treatment can begin and prevent death. A rapid, point-of-care dipstick test is now available for use in screening.